Company news
Quest PharmaTech Inc. news in 2012
Quest PharmaTech Inc.'s news releases, calls and decks from 2012, newest first.
Quest PharmaTech Acquires Immunoglobulin E Technology to Strengthen its Combination Therapy Approach for the Treatment of Cancer
October 2, 2012
Quest PharmaTech Announces Results from its 2012 AGM
July 31, 2012
Quest PharmaTech Updates Progress of Phase II Oregovomab Front-Line Chemo-Immunotherapy Clinical Trial in Italy
July 10, 2012
Quest PharmaTech Initiates Phase II Oregovomab Front-Line Chemo-Immunotherapy Clinical Trial in United States
June 14, 2012
Quest PharmaTech Announces Signing of $8,000,000 Investment Agreement to Support Oregovomab Clinical Trial Programs
June 5, 2012
Quest PharmaTech Announces Financial Results for 2011
May 23, 2012
Quest PharmaTech Announces $500,000 Non-Brokered Private Placement
May 14, 2012